[1] Miyamoto T., Silva M., Hammock B.D., Inhibition of Epoxide Hydrolases and Glutathione S-transferases by 2-, 3-, and 4-Substituted Derivatives of 4′-Phenylchalcone and its Oxide. Arch Biochem Biophys, 254 (1): 203-13 (1987).
[2] Dietze E.C., Kuwano E., Casas J., Hammock B.D., Inhibition of Cytosolic Epoxide Hydrolase by trans-3-Phenylglycidols. Biochem Pharmacol, 42 (6): 1163-75 (1991).
[3] Pecic S., Pakhomova S., Newcomer M.E., Morisseau C., Hammock B.D., Zhu Z., Synthesis and Structure–Activity Relationship of Piperidine-Derived Non-Urea Soluble Epoxide Hydrolase Inhibitors. Bioorg Med Chem Lett; 23 (2): 417-21 (2013).
[4] Shen H.C., Ding F.X., Wang S., Xu S., Chen H.S., Tong X., Discovery of Spirocyclic Secondary Amine-Derived Tertiary Ureas as Highly Potent, Selective and Bioavailable Soluble Epoxide Hydrolase Inhibitors. Bioorg Med Chem Lett, 19 (13): 3398-404(2009).
[5] Xie Y., Liu Y., Gong G., Smith D.H., Yan F., Rinderspacher A., Discovery of Potent Non-Urea Inhibitors of Soluble Epoxide Hydrolase. Bioorg Med Chem Lett, 19 (8): 2354-9 (2009).
[6] Huang S.X., Li H.Y., Liu J.Y., Morisseau C., Hammock B.D., Long Y.Q., Incorporation of Piperazino Functionality into 1,3-Disubstituted Urea as the Tertiary Pharmacophore Affording Potent Inhibitors of Soluble Epoxide Hydrolase with Improved Pharmacokinetic Properties. J Med Chem, 53 (23): 8376-86 (2010).
[7] Kim I.H., Tsai H.J., Nishi K., Kasagami T., Morisseau C., Hammock B.D., 1,3-Disubstituted Ureas Functionalized with Ether Groups are Potent Inhibitors of the Soluble Epoxide Hydrolase with Improved Pharmacokinetic Properties. J Med Chem, 50 (21): 5217-26 (2007).
[8] Shen H.C., Ding F.X., Wang S., Deng Q., Zhang X., Chen Y., Discovery of a Highly Potent, Selective, and Bioavailable Soluble Epoxide Hydrolase Inhibitor with Excellent Ex vivo Target Engagement. J Med Chem, 52 (16): 5009-12 (2009).
[9] Shen H.C., Ding F.X., Deng Q., Xu S., Tong X., Zhang X., A Strategy of Employing Aminoheterocycles as Amide Mimics to Identify Novel, Potent and Bioavailable Soluble Epoxide Hydrolase Inhibitors. Bioorg Med Chem Lett; 19 (19): 5716-21(2009).
[10] ضیایی، عظیم آقابزرگ نانوا، پریچهر؛ لطفی نوسود، یزدان بخش؛ خلیلی، بهزاد؛ تهیه 4 - آریلیدین - 2 - آلکیل تیو - 4H - تیازول - 5 - اون ها با استفاده از آمینواسید های دی تیوکاربامات و آلدهید ها، نشریه شیمی و مهندسی شیمی ایران، 35 (3( : 43-55 (1395)
[11] Schiøtt B., Bruice T.C., Reaction Mechanism of Soluble Epoxide Hydrolase: Insights from Molecular Dynamics Simulations . J Am Chem Soc, 124 (49): 14558-70 (2002).
[12] Morisseau C., Goodrow M.H., Newman J.W., Wheelock C.E., Dowdy D.L., Hammock B.D., Structural Refinement of Inhibitors of Urea-Based Soluble Epoxide Hydrolases. Biocheml pharmacol, 63(9): 1599-608(2002).
[13] Kim I.H., Nishi K., Tsai H.J., Bradford T., Koda Y., Watanabe T., Morisseaua C., Blanchfield J., Toth I., Hammock B.D. , A Design of Bioavailable Derivatives of 12-(3-adamantan-1-yl-ureido)dodecanoic acid, a Potent Inhibitor of the Soluble Epoxide Hydrolase. Bioorg Med Chem, 15 (1): 312-23(2007).
[14] Anandan S.K., Webb H.K., Chen D., Wang Y.X., Aavula B.R., Cases S., 1-(1-Acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea (AR9281) as a Potent, Selective, and Orally Available Soluble Epoxide Hydrolase Inhibitor with Efficacy in Rodent Models of Hypertension and Dysglycemia. Bioorg Med Chem Lett; 21 (3): 983-8(2011).
[15] Pecic S., Deng S.X., Morisseau C., Hammock B.D., Landry D.W., Design, Synthesis and Evaluation of Non-Urea Inhibitors of Soluble Epoxide Hydrolase. Bioorg Med Chem Lett, 22 (1): 601-5 (2012).
[16] Kim I.H., Heirtzler F.R., Morisseau C., Nishi K., Tsai H.J., Hammock B.D., Optimization of Amide-Based Inhibitors of Soluble Epoxide Hydrolase with Improved Water Solubility. J Med Chem, 48 (10): 3621 (2005).
[17] Anandan S.K., Do Z.N., Webb H.K., Patel D.V., Gless R.D., Non-urea Functionality as the Primary Pharmacophore in Soluble Epoxide Hydrolase Inhibitors. Bioorg Med Chem Lett, 19 (4): 1066-70 (2009).
[18] Anandan S.K., Gless R. D., Exploration of Secondary and Tertiary Pharmacophores in Unsymmetrical N,N′-diaryl Urea Inhibitors of Soluble Epoxide Hydrolase. Bioorg Med Chem Lett, 20 (9): 2740-4 (2010).
[19] Li HY., Jin Y., Morisseau C., Hammock B. D., Long Y. Q., The 5-Substituted Piperazine as a Novel Secondary Pharmacophore Greatly Improving the Physical Properties of Urea-Based Inhibitors of Soluble Epoxide Hydrolase. Bioorg Med Chem, 14 (19): 6586-92 (2006).
[20] Rezaee Zavareh E., Hedayati M., Hoghooghi Rad L., Kiani A., Shahhosseini S., Faizi M., Tabatabai S.A., Design, Synthesis and Biological Evaluation of Some Oxadiazole Derivatives as Novel Amide-Based Inhibitors of Soluble Epoxide Hydrolase. Lett Drug Des Discovery, 11 (6): 721-730 (2014).
[21] Rezaee Zavareh E., Hedayati M., Hoghooghi Rad L., Shahhosseini S., Faizi M., Tabatabai S.A., Design, Synthesis and Biological Evaluation of 4-Benzamidobenzoic Acid Hydrazide Derivatives as Novel Soluble Epoxide Hydrolase Inhibitors. Iranian J Pharm Res, 13 (Suppl): 51-59 (2014).
[22] Rezaee E., Hedayati M., Hoghooghi Rad L., Shahhosseini S., Faizi M., Tabatabai S.A., Novel Soluble Epoxide Hydrolase Inhibitors with a Dihydropyrimidinone Scaffold: Design, Synthesis and Biological Evaluation, Med Chem Comm, 7 (11): 2128-35 (2016).
[23] Faizi M., Sheikhha M., Ahangar N., Ghomi HT., Shafaghi B., Shafiee A., Tabatabai S.A., Design, Synthesis and Pharmacological Evaluation of Novel 2-[2-(2-chlorophenoxy) phenyl]-1, 3, 4-Oxadiazole Derivatives as Benzodiazepine Receptor Agonists. Iranian J Pharm Res, 11(1): 83-90 (2012).
[24] Naimi-Jamal M. R., Mokhtari J., Gorban Dekamin M., Javanshir S., Hamzeali H., Efficient Synthesis and Deprotection of Semicarbazones under Solvent-Free Conditions. Iran. Chem. Chem. Eng.(IJCCE), 31(2): 1-8 (2012).